Muscular dystrophies are a group of inherited conditions — including Duchenne, Becker, myotonic, and limb-girdle muscular dystrophy — that cause progressive weakening and wasting of muscle tissue due to genetic mutations. There is currently no treatment that corrects the underlying genetic cause for most types. Standard care focuses on physiotherapy, mobility support, and monitoring of cardiac and respiratory function. Stem Cell Cure India offers an evaluation to help patients and families understand whether stem cell therapy may be relevant to their specific case, alongside — never instead of — ongoing neurology and physiotherapy care.
Muscular dystrophy has no approved treatment that reverses muscle loss for most subtypes, and management is largely limited to physiotherapy, mobility aids, and monitoring of cardiac/respiratory complications. Patients and families who want to understand whether regenerative approaches may be relevant to their specific subtype sometimes seek a specialist evaluation alongside their existing neurology care.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for every patient's individual case.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients with muscular dystrophy before and during their stem cell therapy journey.
Mesenchymal Stem Cells (MSCs) are being studied for their potential to support muscle tissue repair and reduce inflammation in some muscular dystrophy research. Stem cell therapy does not correct the underlying genetic mutation, and is not established as a treatment that restores muscle strength already lost. This approach is explored as a complement to — not a replacement for — physiotherapy, mobility support, and cardiac/respiratory monitoring by the patient's neurology team.
Suitability depends on the specific type of muscular dystrophy, stage of disease, and current mobility and cardiopulmonary status. Before travelling, our team reviews:
No. Muscular dystrophy is a genetic condition, and stem cell therapy does not correct the underlying mutation. It is explored as an option that may help support muscle health, alongside physiotherapy and neurology care — it is not a cure.
This varies by the specific type and stage of muscular dystrophy, and current cardiac/respiratory status. Please share your CK levels, genetic report, and cardiac/pulmonary evaluation so our team can give an initial opinion.
CK blood test, genetic test report if available, EMG results if performed, and recent cardiac/pulmonary evaluation.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up and treatment plan required.
Yes. Once an evaluation is confirmed, we provide the invitation and supporting documents needed to apply for a Medical Visa.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
